• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

作为流感病毒神经氨酸酶有效抑制剂的硫脲类似物的对接和 3D-QSAR 研究。

Docking and 3D QSAR study of thiourea analogs as potent inhibitors of influenza virus neuraminidase.

机构信息

College of Bioengineering, Chongqing University, Chongqing 400044, China.

出版信息

J Mol Model. 2010 Dec;16(12):1809-18. doi: 10.1007/s00894-010-0685-9. Epub 2010 Mar 7.

DOI:10.1007/s00894-010-0685-9
PMID:20213331
Abstract

Surflex-Dock was applied to study interactions between 30 thiourea analogs and neuraminidase (NA). The docking results showed that hydrogen bonding and electrostatic interactions were highly correlated with the activities of neuraminidase inhibitors (NIs), followed by hydrophobic and steric factors. Moreover, there was a strong correlation between the predicted binding affinity (total score) and experimental pIC₅₀ (correlation coefficient r = 0.870; P < 0.0001). A three dimensional holographic vector of atomic interaction field (3D-HoVAIF) was employed to construct a QSAR model. The r², q² and r² (test) values of the optimal QSAR model were 0.849, 0.724 and 0.689, respectively. From the QSAR model, it could be seen that electrostatic, hydrophobic and steric interactions were closely related to inhibitory activity, which was consistent with the docking results. Based on the docking and QSAR results, five new compounds with high predicted activities were designed.

摘要

Surflex-Dock 被应用于研究 30 种硫脲类似物与神经氨酸酶(NA)之间的相互作用。对接结果表明,氢键和静电相互作用与神经氨酸酶抑制剂(NAIs)的活性高度相关,其次是疏水和空间位阻因素。此外,预测的结合亲和力(总得分)与实验 pIC₅₀之间存在很强的相关性(相关系数 r=0.870;P<0.0001)。采用三维原子相互作用场全息向量(3D-HoVAIF)构建了一个 QSAR 模型。最佳 QSAR 模型的 r²、q² 和 r²(测试)值分别为 0.849、0.724 和 0.689。从 QSAR 模型可以看出,静电、疏水和空间位阻相互作用与抑制活性密切相关,这与对接结果一致。基于对接和 QSAR 结果,设计了五个具有高预测活性的新化合物。

相似文献

1
Docking and 3D QSAR study of thiourea analogs as potent inhibitors of influenza virus neuraminidase.作为流感病毒神经氨酸酶有效抑制剂的硫脲类似物的对接和 3D-QSAR 研究。
J Mol Model. 2010 Dec;16(12):1809-18. doi: 10.1007/s00894-010-0685-9. Epub 2010 Mar 7.
2
Molecular docking and QSAR studies on substituted acyl(thio)urea and thiadiazolo [2,3-alpha] pyrimidine derivatives as potent inhibitors of influenza virus neuraminidase.取代酰基(硫)脲和噻二唑并[2,3-α]嘧啶衍生物作为流感病毒神经氨酸酶抑制剂的分子对接和定量构效关系研究。
Chem Biol Drug Des. 2010 Sep 1;76(3):245-54. doi: 10.1111/j.1747-0285.2010.01006.x. Epub 2010 Jul 5.
3
3D QSAR and docking study of flavone derivatives as potent inhibitors of influenza H1N1 virus neuraminidase.三维定量构效关系和对接研究黄酮衍生物作为流感 H1N1 病毒神经氨酸酶的有效抑制剂。
Bioorg Med Chem Lett. 2011 Oct 1;21(19):5964-70. doi: 10.1016/j.bmcl.2011.07.071. Epub 2011 Jul 26.
4
Docking and 3D-QSAR studies of influenza neuraminidase inhibitors using three-dimensional holographic vector of atomic interaction field analysis.利用三维原子相互作用场全息向量分析对流感神经氨酸酶抑制剂进行对接和 3D-QSAR 研究。
Eur J Med Chem. 2010 Mar;45(3):1008-14. doi: 10.1016/j.ejmech.2009.11.043. Epub 2009 Nov 27.
5
Docking and 3D-QSAR investigations of pyrrolidine derivatives as potent neuraminidase inhibitors.作为强效神经氨酸酶抑制剂的吡咯烷衍生物的对接和 3D-QSAR 研究。
Chem Biol Drug Des. 2012 May;79(5):863-8. doi: 10.1111/j.1747-0285.2012.01330.x. Epub 2012 Feb 15.
6
Binding interaction analysis of the active site and its inhibitors for neuraminidase (N1 subtype) of human influenza virus by the integration of molecular docking, FMO calculation and 3D-QSAR CoMFA modeling.通过分子对接、FMO计算和3D-QSAR CoMFA建模相结合的方法对人流感病毒神经氨酸酶(N1亚型)活性位点及其抑制剂进行结合相互作用分析。
J Chem Inf Model. 2008 Sep;48(9):1802-12. doi: 10.1021/ci800041k. Epub 2008 Aug 16.
7
QSAR analyses on avian influenza virus neuraminidase inhibitors using CoMFA, CoMSIA, and HQSAR.使用比较分子场分析(CoMFA)、比较分子相似性指数分析(CoMSIA)和全息定量构效关系(HQSAR)对禽流感病毒神经氨酸酶抑制剂进行定量构效关系分析。
J Comput Aided Mol Des. 2006 Sep;20(9):549-66. doi: 10.1007/s10822-006-9080-0. Epub 2006 Nov 11.
8
QSAR modeling and molecular interaction analysis of natural compounds as potent neuraminidase inhibitors.天然化合物作为强效神经氨酸酶抑制剂的定量构效关系建模与分子相互作用分析
Mol Biosyst. 2016 Apr 26;12(5):1667-75. doi: 10.1039/c6mb00123h.
9
Structure-based and multiple potential three-dimensional quantitative structure-activity relationship (SB-MP-3D-QSAR) for inhibitor design.基于结构的和多重潜在三维定量构效关系 (SB-MP-3D-QSAR) 在抑制剂设计中的应用。
J Chem Inf Model. 2012 Apr 23;52(4):996-1004. doi: 10.1021/ci300066y. Epub 2012 Apr 13.
10
Hyphenated 3D-QSAR statistical model-drug repurposing analysis for the identification of potent neuraminidase inhibitor.用于鉴定强效神经氨酸酶抑制剂的联用3D-QSAR统计模型-药物再利用分析
Cell Biochem Biophys. 2018 Sep;76(3):357-376. doi: 10.1007/s12013-018-0844-7. Epub 2018 Apr 23.

引用本文的文献

1
In Silico Exploration of Aryl Halides Analogues as Checkpoint Kinase 1 Inhibitors by Using 3D QSAR, Molecular Docking Study, and ADMET Screening.利用3D QSAR、分子对接研究和ADMET筛选对卤代芳烃类似物作为检查点激酶1抑制剂进行计算机模拟探索
Adv Pharm Bull. 2019 Feb;9(1):84-92. doi: 10.15171/apb.2019.011. Epub 2019 Feb 21.
2
In Silico Analysis of the Association Relationship between Neuroprotection and Flavors of Traditional Chinese Medicine Based on the mGluRs.基于代谢型谷氨酸受体的中药五味与神经保护作用的关联关系的计算分析
Int J Mol Sci. 2018 Jan 10;19(1):163. doi: 10.3390/ijms19010163.
3
Designing of inhibitors against drug tolerant Mycobacterium tuberculosis (H37Rv).

本文引用的文献

1
Antiviral treatment and prevention of seasonal influenza: a comparative review of recommendations in the European Union.
J Clin Virol. 2008 Jul;42(3):244-8. doi: 10.1016/j.jcv.2008.04.001. Epub 2008 May 19.
2
QSAR study of neuraminidase inhibitors based on heuristic method and radial basis function network.基于启发式方法和径向基函数网络的神经氨酸酶抑制剂的定量构效关系研究
Eur J Med Chem. 2008 Mar;43(3):569-76. doi: 10.1016/j.ejmech.2007.04.011. Epub 2007 May 13.
3
Synthesis of potent pyrrolidine influenza neuraminidase inhibitors.
Bioorg Med Chem Lett. 2008 Mar 1;18(5):1692-5. doi: 10.1016/j.bmcl.2008.01.048. Epub 2008 Jan 18.
4
针对耐药物结核分枝杆菌(H37Rv)的抑制剂设计。
Chem Cent J. 2013 Mar 8;7(1):49. doi: 10.1186/1752-153X-7-49.
4
Pyrrolo[3,2-d]pyrimidine derivatives as type II kinase insert domain receptor (KDR) inhibitors: CoMFA and CoMSIA studies.作为II型激酶插入结构域受体(KDR)抑制剂的吡咯并[3,2-d]嘧啶衍生物:比较分子场分析(CoMFA)和比较分子相似性指数分析(CoMSIA)研究
Int J Mol Sci. 2012;13(2):2387-2404. doi: 10.3390/ijms13022387. Epub 2012 Feb 22.
5
A web server for predicting inhibitors against bacterial target GlmU protein.一个用于预测针对细菌靶标GlmU蛋白的抑制剂的网络服务器。
BMC Pharmacol. 2011 Jul 6;11:5. doi: 10.1186/1471-2210-11-5.
6
Combined 3D-QSAR modeling and molecular docking studies on pyrrole-indolin-2-ones as Aurora A kinase inhibitors.基于吡咯-吲哚啉-2-酮类作为极光激酶A抑制剂的组合3D-QSAR建模与分子对接研究
Int J Mol Sci. 2011;12(3):1605-24. doi: 10.3390/ijms12031605. Epub 2011 Mar 1.
A ligand's-eye view of protein binding.从配体角度看蛋白质结合。
J Comput Aided Mol Des. 2008 Jun-Jul;22(6-7):507-21. doi: 10.1007/s10822-008-9177-8. Epub 2008 Jan 24.
5
Is it possible to increase hit rates in structure-based virtual screening by pharmacophore filtering? An investigation of the advantages and pitfalls of post-filtering.通过药效团过滤能否提高基于结构的虚拟筛选中的命中率?对过滤后优势和陷阱的调查。
J Mol Graph Model. 2008 Jun;26(8):1237-51. doi: 10.1016/j.jmgm.2007.11.005. Epub 2007 Nov 29.
6
Quantitative structure activity relationship studies on thiourea analogues as influenza virus neuraminidase inhibitors.关于硫脲类似物作为流感病毒神经氨酸酶抑制剂的定量构效关系研究。
Eur J Med Chem. 2008 Feb;43(2):293-9. doi: 10.1016/j.ejmech.2007.03.020. Epub 2007 Apr 5.
7
Synthesis and evaluation of a new series of substituted acyl(thio)urea and thiadiazolo [2,3-a] pyrimidine derivatives as potent inhibitors of influenza virus neuraminidase.新型取代酰基(硫代)脲和噻二唑并[2,3-a]嘧啶衍生物作为流感病毒神经氨酸酶强效抑制剂的合成与评价
Bioorg Med Chem. 2006 Dec 15;14(24):8574-81. doi: 10.1016/j.bmc.2006.08.034. Epub 2006 Sep 18.
8
A QSAR study on influenza neuraminidase inhibitors.一项关于流感神经氨酸酶抑制剂的定量构效关系研究。
Bioorg Med Chem. 2006 Feb 15;14(4):982-96. doi: 10.1016/j.bmc.2005.09.016. Epub 2005 Oct 6.
9
Estimating protein-ligand binding free energy: atomic solvation parameters for partition coefficient and solvation free energy calculation.估算蛋白质-配体结合自由能:用于分配系数和溶剂化自由能计算的原子溶剂化参数
Proteins. 2004 Dec 1;57(4):651-64. doi: 10.1002/prot.20198.
10
Hydropathic interaction analyses of small organic activators binding to antithrombin.与抗凝血酶结合的小有机激活剂的水合作用分析
Bioorg Med Chem. 2004 Feb 1;12(3):633-40. doi: 10.1016/j.bmc.2003.10.034.